Skip to main content
Erschienen in: Journal of Cancer Education 1/2013

01.03.2013

American Indian Perceptions of Colorectal Cancer Screening: Viewpoints from Adults Under Age 50

verfasst von: Melissa K. Filippi, Stacy Braiuca, Lance Cully, Aimee S. James, Won S. Choi, K. Allen Greiner, Christine M. Daley

Erschienen in: Journal of Cancer Education | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer (CRC) mortality rates have decreased in the general US population; however, CRC mortality rates are increasing among American Indians (AI). AI CRC screening rates remain low when compared to other ethnic groups. Our team investigated CRC screening education prior to recommended age for screening to better understand screening perceptions among AI community members. Our research team conducted 11 focus groups with AI men and women aged 30–49 (N = 39 men and N = 31 women) in Kansas and Missouri. The results revealed that community members (1) have little knowledge of CRC, (2) do not openly discuss CRC, and (3) want additional CRC education. Variations existed among men and women's groups, but they agreed that preventive measures need to be appropriate for AI communities. Thus, AI CRC screening interventions should be culturally tailored to better meet the needs of the population.
Literatur
2.
Zurück zum Zitat Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS (2009) Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 115(9):1967–1976. doi:10.1002/cncr.24216 PubMedCrossRef Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS (2009) Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 115(9):1967–1976. doi:10.​1002/​cncr.​24216 PubMedCrossRef
3.
Zurück zum Zitat Espey D, Paisano R, Cobb N (2003) Cancer mortality among American Indians and Alaska Natives: regional differences, 1994–1998. Indian Health Service, Rockville, IHS Pub. No. 97-615-28 Espey D, Paisano R, Cobb N (2003) Cancer mortality among American Indians and Alaska Natives: regional differences, 19941998. Indian Health Service, Rockville, IHS Pub. No. 97-615-28
4.
Zurück zum Zitat Day GE, Provost E, Lanier AP (2009) Alaska native mortality rates and trends. Public Health Rep 124(1):54–64PubMed Day GE, Provost E, Lanier AP (2009) Alaska native mortality rates and trends. Public Health Rep 124(1):54–64PubMed
5.
Zurück zum Zitat Lanier AP, Day GE, Kelly JJ, Provost E (2008) Disparities in cancer mortality among Alaska Native people, 1994–2003. Alaska Med 49(4):120–125PubMed Lanier AP, Day GE, Kelly JJ, Provost E (2008) Disparities in cancer mortality among Alaska Native people, 1994–2003. Alaska Med 49(4):120–125PubMed
6.
Zurück zum Zitat Perdue DG, Perkins C, Jackson-Thompson J, Coughlin SS, Ahmed F, Haverkamp DS, Jim MA (2008) Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999–2004. Cancer 113(5 Suppl):1179–1190. doi:10.1002/cncr.23726 PubMedCrossRef Perdue DG, Perkins C, Jackson-Thompson J, Coughlin SS, Ahmed F, Haverkamp DS, Jim MA (2008) Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999–2004. Cancer 113(5 Suppl):1179–1190. doi:10.​1002/​cncr.​23726 PubMedCrossRef
7.
Zurück zum Zitat Frost F, Taylor V, Fries E (1992) Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst 84(12):957–962PubMedCrossRef Frost F, Taylor V, Fries E (1992) Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst 84(12):957–962PubMedCrossRef
8.
Zurück zum Zitat Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
11.
Zurück zum Zitat Rosenberg T, Martel S (1998) Cancer trends from 1972–1991 for registered Indians living on Manitoba Reserves. Int J Circumpolar Health 57(Suppl 1):391–398PubMed Rosenberg T, Martel S (1998) Cancer trends from 1972–1991 for registered Indians living on Manitoba Reserves. Int J Circumpolar Health 57(Suppl 1):391–398PubMed
12.
Zurück zum Zitat Jim M (2007) Cancer in American Indians: data linkages. Southern Plains Inter-tribal Epidemiology Center, Oklahoma City Area Indian Health Board Report to the Tribes: cancer update. Southern Plains Inter-tribal Epidemiology Center, Oklahoma Jim M (2007) Cancer in American Indians: data linkages. Southern Plains Inter-tribal Epidemiology Center, Oklahoma City Area Indian Health Board Report to the Tribes: cancer update. Southern Plains Inter-tribal Epidemiology Center, Oklahoma
13.
Zurück zum Zitat Yankaskas BC, Knight KL, Fleg A, Rao C (2009) Misclassification of American Indian race in state cancer data among non-federally recognized Indians in North Carolina. J Regist Manag 36(1):7–11 Yankaskas BC, Knight KL, Fleg A, Rao C (2009) Misclassification of American Indian race in state cancer data among non-federally recognized Indians in North Carolina. J Regist Manag 36(1):7–11
14.
Zurück zum Zitat Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH et al (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112(2):594–642PubMedCrossRef Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH et al (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112(2):594–642PubMedCrossRef
15.
Zurück zum Zitat Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365–1371PubMedCrossRef Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365–1371PubMedCrossRef
16.
Zurück zum Zitat Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437PubMedCrossRef Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437PubMedCrossRef
17.
Zurück zum Zitat Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343(22):1603–1607PubMedCrossRef Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343(22):1603–1607PubMedCrossRef
18.
Zurück zum Zitat Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657PubMedCrossRef Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657PubMedCrossRef
19.
Zurück zum Zitat Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM (1998) Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42(4):560–565PubMedCrossRef Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM (1998) Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42(4):560–565PubMedCrossRef
20.
Zurück zum Zitat Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572–1575PubMedCrossRef Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572–1575PubMedCrossRef
21.
Zurück zum Zitat Winawer SJ, Zauber AG (2001) Colonoscopic polypectomy and the incidence of colorectal cancer. Gut 48(6):753–754PubMedCrossRef Winawer SJ, Zauber AG (2001) Colonoscopic polypectomy and the incidence of colorectal cancer. Gut 48(6):753–754PubMedCrossRef
22.
Zurück zum Zitat Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329(27):1977–1981PubMedCrossRef Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329(27):1977–1981PubMedCrossRef
23.
Zurück zum Zitat Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case–control study of 32,702 veterans. Ann Intern Med 123(12):904–910PubMed Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case–control study of 32,702 veterans. Ann Intern Med 123(12):904–910PubMed
24.
Zurück zum Zitat Seeff LC, Shapiro JA, Nadel MR (2002) Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 51(9):761–766PubMed Seeff LC, Shapiro JA, Nadel MR (2002) Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 51(9):761–766PubMed
25.
Zurück zum Zitat Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L (2001) Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 91(8):1264–1272PubMedCrossRef Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L (2001) Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 91(8):1264–1272PubMedCrossRef
26.
Zurück zum Zitat From the Centers for Disease Control and Prevention (1997) Self-reported use of mammography among women aged > or =40 years—United States, 1989 and 1995. JAMA 278(17):1395–1396CrossRef From the Centers for Disease Control and Prevention (1997) Self-reported use of mammography among women aged > or =40 years—United States, 1989 and 1995. JAMA 278(17):1395–1396CrossRef
27.
Zurück zum Zitat Sirovich BE, Schwartz LM, Woloshin S (2003) Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289(11):1414–1420PubMedCrossRef Sirovich BE, Schwartz LM, Woloshin S (2003) Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289(11):1414–1420PubMedCrossRef
28.
Zurück zum Zitat Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152. doi:10.1002/cncr.23044 PubMedCrossRef Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152. doi:10.​1002/​cncr.​23044 PubMedCrossRef
30.
Zurück zum Zitat Day LW, Espey DK, Madden E, Segal M, Terdiman JP (2011) Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan Natives in the Indian Health Service. Dig Dis Sci 56(7):2104–2113. doi:10.1007/s10620-010-1528-3 PubMedCrossRef Day LW, Espey DK, Madden E, Segal M, Terdiman JP (2011) Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan Natives in the Indian Health Service. Dig Dis Sci 56(7):2104–2113. doi:10.​1007/​s10620-010-1528-3 PubMedCrossRef
31.
Zurück zum Zitat Holm JE, Vogeltanz-Holm N, Poltavski D, McDonald L (2010) Assessing health status, behavioral risks, and health disparities in American Indians living on the northern plains of the U.S. Public Health Rep 125(1):68–78PubMed Holm JE, Vogeltanz-Holm N, Poltavski D, McDonald L (2010) Assessing health status, behavioral risks, and health disparities in American Indians living on the northern plains of the U.S. Public Health Rep 125(1):68–78PubMed
32.
Zurück zum Zitat Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw KM (2008) Surveillance for health behaviors of American Indians and Alaska Natives—findings from the behavioral risk factor surveillance system, 2000–2006. Cancer 113(5 Suppl):1131–1141. doi:10.1002/cncr.23727 PubMedCrossRef Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw KM (2008) Surveillance for health behaviors of American Indians and Alaska Natives—findings from the behavioral risk factor surveillance system, 2000–2006. Cancer 113(5 Suppl):1131–1141. doi:10.​1002/​cncr.​23727 PubMedCrossRef
33.
Zurück zum Zitat Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040):1472–1477PubMedCrossRef Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040):1472–1477PubMedCrossRef
34.
Zurück zum Zitat Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, Petereit D (2009) Assessing cancer stage and screening disparities among Native American cancer patients. Public Health Rep 124(1):79–89PubMed Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, Petereit D (2009) Assessing cancer stage and screening disparities among Native American cancer patients. Public Health Rep 124(1):79–89PubMed
35.
Zurück zum Zitat Bejes C, Marvel MK (1992) Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J 12(1):83–90PubMed Bejes C, Marvel MK (1992) Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J 12(1):83–90PubMed
36.
Zurück zum Zitat Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L (1991) Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 29(10):1039–1050PubMedCrossRef Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L (1991) Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 29(10):1039–1050PubMedCrossRef
37.
Zurück zum Zitat Arveux P, Durand G, Milan C, Bedenne L, Levy D, Doan BD, Faivre J (1992) Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev Med 21(5):574–581PubMedCrossRef Arveux P, Durand G, Milan C, Bedenne L, Levy D, Doan BD, Faivre J (1992) Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev Med 21(5):574–581PubMedCrossRef
38.
Zurück zum Zitat Hunter W, Farmer A, Mant D, Verne J, Northover J, Fitzpatrick R (1991) The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited. Fam Pract 8(4):367–372PubMedCrossRef Hunter W, Farmer A, Mant D, Verne J, Northover J, Fitzpatrick R (1991) The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited. Fam Pract 8(4):367–372PubMedCrossRef
39.
Zurück zum Zitat Powe BD (1995) Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 18(5):385–392PubMedCrossRef Powe BD (1995) Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 18(5):385–392PubMedCrossRef
40.
Zurück zum Zitat Hoogewerf PE, Hislop TG, Morrison BJ, Burns SD, Sizto R (1990) Health belief and compliance with screening for fecal occult blood. Soc Sci Med 30(6):721–726PubMedCrossRef Hoogewerf PE, Hislop TG, Morrison BJ, Burns SD, Sizto R (1990) Health belief and compliance with screening for fecal occult blood. Soc Sci Med 30(6):721–726PubMedCrossRef
41.
Zurück zum Zitat Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE (1990) Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med 32(1):46–51PubMedCrossRef Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE (1990) Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med 32(1):46–51PubMedCrossRef
42.
Zurück zum Zitat Vernon SW, Gilstrap EL, Jackson GL, Hughes JI (1992) An intervention to increase participation in a work site cancer screening program. Health Values 16:3–9 Vernon SW, Gilstrap EL, Jackson GL, Hughes JI (1992) An intervention to increase participation in a work site cancer screening program. Health Values 16:3–9
44.
Zurück zum Zitat James AS, Campbell MK, Hudson MA (2002) Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomark Prev 11(6):529–534 James AS, Campbell MK, Hudson MA (2002) Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomark Prev 11(6):529–534
46.
Zurück zum Zitat Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43(9):939–944PubMedCrossRef Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43(9):939–944PubMedCrossRef
47.
Zurück zum Zitat Daley CM, James AS, Filippi M, Weir M, Braiuca S, Kaur B, Choi WS, Greiner KA (2012) American Indian community leader and provider views of needs and barriers to colorectal cancer screening. J Health Disparities Res Pract 5(2) Daley CM, James AS, Filippi M, Weir M, Braiuca S, Kaur B, Choi WS, Greiner KA (2012) American Indian community leader and provider views of needs and barriers to colorectal cancer screening. J Health Disparities Res Pract 5(2)
48.
Zurück zum Zitat Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, Given CW (2002) Colorectal cancer screening barriers in persons with low income. Cancer Pract 10(5):240–247PubMedCrossRef Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, Given CW (2002) Colorectal cancer screening barriers in persons with low income. Cancer Pract 10(5):240–247PubMedCrossRef
49.
Zurück zum Zitat Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conaway M, Woods-Powell CT (1996) Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J Commun Health 21(6):409–427CrossRef Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conaway M, Woods-Powell CT (1996) Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J Commun Health 21(6):409–427CrossRef
50.
Zurück zum Zitat O'Malley AS, Forrest CB, Mandelblatt J (2002) Adherence of low-income women to cancer screening recommendations: the roles of primary care health insurance, and HMOs. J Gen Intern Med 17:144–154PubMedCrossRef O'Malley AS, Forrest CB, Mandelblatt J (2002) Adherence of low-income women to cancer screening recommendations: the roles of primary care health insurance, and HMOs. J Gen Intern Med 17:144–154PubMedCrossRef
51.
Zurück zum Zitat Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L (2008) Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19(7):725–737. doi:10.1007/s10552-008-9135-8 PubMedCrossRef Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L (2008) Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19(7):725–737. doi:10.​1007/​s10552-008-9135-8 PubMedCrossRef
52.
54.
Zurück zum Zitat Ellerbeck EF, Engelman KK, Gladden J, Mosier MC, Raju GS, Ahluwalia JS (2001) Direct observation of counseling on colorectal cancer in rural primary care practices. J Gen Intern Med 16(10):697–700PubMedCrossRef Ellerbeck EF, Engelman KK, Gladden J, Mosier MC, Raju GS, Ahluwalia JS (2001) Direct observation of counseling on colorectal cancer in rural primary care practices. J Gen Intern Med 16(10):697–700PubMedCrossRef
55.
Zurück zum Zitat Daley CM, James AS, Ulrey E, Joseph S, Talawyma A, Choi WS, Greiner KA, Coe MK (2010) Using focus groups in community-based participatory research: challenges and resolutions. Qual Heal Res 20(5):697–706. doi:10.1177/1049732310361468 CrossRef Daley CM, James AS, Ulrey E, Joseph S, Talawyma A, Choi WS, Greiner KA, Coe MK (2010) Using focus groups in community-based participatory research: challenges and resolutions. Qual Heal Res 20(5):697–706. doi:10.​1177/​1049732310361468​ CrossRef
Metadaten
Titel
American Indian Perceptions of Colorectal Cancer Screening: Viewpoints from Adults Under Age 50
verfasst von
Melissa K. Filippi
Stacy Braiuca
Lance Cully
Aimee S. James
Won S. Choi
K. Allen Greiner
Christine M. Daley
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 1/2013
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0428-y

Weitere Artikel der Ausgabe 1/2013

Journal of Cancer Education 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.